New PreMiEr Preprint: CRISPR Shows Potential for Hospital Microbiome Engineering, But Real-World Use Remains Distant

3/23/26 News 1 min read

A new PreMiEr scoping review finds CRISPR shows lab-based promise for targeting hospital pathogens, but no real-world healthcare applications exist yet, highlighting a major gap between concept and practice.

Duke Chapel — New PreMiEr Preprint: CRISPR Shows Potential for Hospital Microbiome Engineering, But Real-World Use Remains Distant

A systematic scoping review by PreMiEr researchers finds that CRISPR technologies hold real promise for targeting dangerous pathogens in healthcare built environments, but that no real-world applications have yet been tested in actual healthcare facilities. Lab studies show that CRISPR can modify key pathogen traits including biofilm formation, adhesion, and virulence, but a significant gap remains between these early findings and practical infection prevention. The review, published on Zenodo, calls for ecologically informed models and standardized evaluation frameworks to safely move CRISPR approaches from the laboratory into clinical settings.